---
figid: PMC5777796__oncotarget-08-115596-g007
figlink: /pmc/articles/PMC5777796/figure/F7/
number: Figure 7
caption: In the resting state (left panel), Sur8 is maintained at a low level by PKCα-
  and PKCδ-mediated phosphorylation at Thr-71 and Ser-297, respectively, and is subsequently
  degraded. This results in a basal level of cell proliferation. Upon FGF2 stimulation
  (right panel), Sur8 is maintained at a high level by stabilization through degradation
  of PKCα/δ. The stabilized Sur8 promotes transformation and migration of cells via
  activation of the Ras/ERK pathway.
pmcid: PMC5777796
papertitle: Stabilization of Sur8 via PKCα/δ degradation promotes transformation and
  migration of colorectal cancer cells.
reftext: Kug Hwa Lee, et al. Oncotarget. 2017 Dec 29;8(70):115596-115608.
pmc_ranked_result_index: '31778'
pathway_score: 0.954486
filename: oncotarget-08-115596-g007.jpg
figtitle: Stabilization of Sur8 via PKCA/D degradation promotes transformation and
  migration of colorectal cancer cells
year: '2017'
organisms: Homo sapiens
ndex: a2b3cc03-deaa-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5777796__oncotarget-08-115596-g007.html
  '@type': Dataset
  description: In the resting state (left panel), Sur8 is maintained at a low level
    by PKCα- and PKCδ-mediated phosphorylation at Thr-71 and Ser-297, respectively,
    and is subsequently degraded. This results in a basal level of cell proliferation.
    Upon FGF2 stimulation (right panel), Sur8 is maintained at a high level by stabilization
    through degradation of PKCα/δ. The stabilized Sur8 promotes transformation and
    migration of cells via activation of the Ras/ERK pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARAF
  - MAPK3
  - KRAS
  - RAF1
  - MAP2K1
  - MAPK1
  - NRAS
  - BRAF
  - HRAS
  - SHOC2
  - MAP2K2
  - PRKCA
  - FGF2
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Sur8
  symbol: SUR-8
  source: hgnc_alias_symbol
  hgnc_symbol: SHOC2
  entrez: '8036'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKCA/o
  symbol: PKCA
  source: hgnc_prev_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: FGF2
  symbol: FGF2
  source: hgnc_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
